Qsymia
Payments companies reported to CMS as associated with Qsymia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Qsymia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Qsymia
These are the largest totals companies reported as associated with Qsymia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thomas Najarian | Los Osos, CA | $544,673.16 | |
| Andres Acosta | Rochester, MN | Gastroenterology (Internal Medicine) | $92,272.09 |
| Anthony Auriemma | Westmont, IL | Family Medicine | $86,440.79 |
| Sherry Sakowitz | Brooklyn, NY | Pediatrics | $21,280.93 |
| Robert Kushner | Chicago, IL | Internal Medicine | $16,400.00 |
| Marina Kurian | New York, NY | Surgery | $12,770.85 |
| Karlijn Burridge | Westmont, IL | Physician Assistant | $6,963.71 |
| Suzanne Cuda | San Antonio, TX | Obesity Medicine (Pediatrics) | $5,278.00 |
| Cynthia Rudert | Atlanta, GA | Gastroenterology (Internal Medicine) | $2,780.15 |
| Mark Jabro | San Diego, CA | Internal Medicine | $1,800.00 |
Prescribed Qsymia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.